Hepatitis B therapeutic drug (vaccine, medicine) market size, demand & global opportunity analysis...
-
Upload
nick-price -
Category
Health & Medicine
-
view
105 -
download
0
Transcript of Hepatitis B therapeutic drug (vaccine, medicine) market size, demand & global opportunity analysis...
Copyright © Research Nester Pvt. Ltd. www.researchnester.com
Global Hepatitis B Therapeutic Drug Market Outlook :
Industry Insights & Opportunity Evaluation,
2015-2021
Copyright © Research Nester Pvt. Ltd. www.researchnester.com
Research Nester, currently serving clients from 120+ countries
clients across the globe, is a leading service provider for
strategic market research and consulting. We aim to provide
unbiased, unparalleled market insights and industry analysis to
help industries, conglomerates and executives to take wise
decisions for their future marketing strategy, expansion and
investment etc. We believe every business can expand to its new
horizon, provided a right guidance at a right time is available
through strategic minds. Our out of box thinking helps our
clients to take wise decision so as to avoid future uncertainties.
Through our robust, unbiased extensive primary and secondary
research, we help organizations to understand current and
future market trends, thus letting them making a prolonged yet
dynamic financial investment.
Entering New Emerging Markets
Launch & Viability of Product
Competitive Analysis
Industry Analysis
Copyright © Research Nester Pvt. Ltd. www.researchnester.com
Real Estate
Food & Beverage
FMCG
Industries
Catered
Energy & Power
Healthcare
Information Technology
Semiconductor
ICT
Copyright © Research Nester Pvt. Ltd. www.researchnester.com
Our Services
Actionable Insight
Data Collection
Business Solution
Research & Analysis
Data Analysis
Primary
Research
Secondary
/Desk
Research
Company
Analysis
Recommendation Competition
Study
Channel
Assessment
Study of
Developme
nts
Market
Assessment
/Estimation
s/Forecast
Future
Share
Target
Market
In-depth Industry Analysis
Our exhaustive research reports are a combination of qualitative and quantitative data and analysis Research conducted using credible database and industry tools and primary insights Unbiased and detailed analysis of financial statistics, competitor’s analysis Market size estimation (by value and volume) and forecasting Detailed mapping on SWOT Analysis, Porters’ Five Force Model Analysis, PESTEL Analysis
Custom Research Services
Tracking the market as per the industry’s movement Conducting interviews to portray real situations and industry’s trends In-depth analysis and information gathering as per client’s requirement Provide 360 degree approach reports to meet client’s specific requirement
We Offer
Copyright © Research Nester Pvt. Ltd. www.researchnester.com
Sample Research Presentation Look for Your
Requested Research/TOC
Copyright © Research Nester Pvt. Ltd. www.researchnester.com
Global Hepatitis B Therapeutic Drug Market
Overview
Hepatitis B, a leading cause of human mortalities across
the globe, is a fatal disease which leads to infections in the
liver. A person suffering from Hepatitis B needs proper
and intensive care which is provided through various
therapeutic drugs of Hepatitis B available in the market.
Global hepatitis B therapeutic drug market was valued at
approximately USD 3.2 Billion in 2014 and is anticipated
to foster at a modest compound annual growth rate
(CAGR) of 2.6% over the forecast period i.e. 2015-2021.
Geographically, the market is segmented into North
America, Latin America, Western and Eastern Europe,
Asia-Pacific and Rest of World. Asia-Pacific hepatitis B
therapeutic market is envisioned to behold the fastest
growth in coming 5-6 years.
Copyright © Research Nester Pvt. Ltd. www.researchnester.com
Global Hepatitis B Therapeutic Drug Market Size
(USD Billion) & Y-O-Y (%) Analysis, 2015-2021
Source: Research Nester
Market Segmentation
By Products
On the basis of products, the global hepatitis B therapeutic
drug market is segmented into:
Baraclude
Pegasys
Tyzeka
3.29
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
45.00%
50.00%
0
5
10
15
20
25
30
35
40
45
2015e 2016f 2017f 2018f 2019f 2020f 2021f
Market Size Y-O-Y Growth
Copyright © Research Nester Pvt. Ltd. www.researchnester.com
Baraclude
Hepsera
Others
By Demography
Global hepatitis B therapeutic drug market can be
segmented based on demography
Male
Female
By Types
Based on the patents, the global hepatitis B market is
divided into
Generic Drugs
Branded Drugs
Growth Drivers and challenges
Increasing incidences of Hepatitis B, rising government
and non-government organizations’ initiatives to promote
use of hepatitis drugs are believed to drive the global
hepatitis B therapeutic drug market over the forecast
period.
However, high cost of hepatitis B drugs and complex
regulatory procedures are likely to dampen the growth of
the market in future.
Copyright © Research Nester Pvt. Ltd. www.researchnester.com
Market Size and Forecast
North America dominates the global hepatitis B
therapeutic drug market in the world. The hepatitis B drug
market in North America is sparked by higher spending of
government on healthcare industry. The U.S. and Canada
are two major markets of hepatitis B drugs in North
America. The U.S. Hepatitis B drug market is likely to get
fostered by increasing immigration of hepatitis B patients
from emerging nations.
Europe is also expected to account for a larger share of the
global hepatitis B therapeutic drug market during the
forecast period. The market is likely to get propelled by
rising incidence of various types of hepatitis in some of the
major countries such as Germany, Spain, Italy, U.K.,
France, and Hungary.
Asia-Pacific hepatitis B therapeutic drug market is
forecasted to have the highest growth rate owing to
increasing healthcare infrastructure in countries such as
India and China. In addition to that, increase in aging
population in japan is further expected to boost the
hepatitis B therapeutic drug market in the region.
Key Players
The global hepatitis B therapeutic drug market includes
some of the top players such as GlaxoSmithKline, Bristol-
Myers Squibb Company, Mitsubishi Tanabe Pharma
Copyright © Research Nester Pvt. Ltd. www.researchnester.com
Corporation, Johnson & Johnson, F. Hoffmann-La Roche
Ltd., Gilead Sciences Inc., Merck & Co. Inc., Novartis AG,
AbbVie Inc., etc.
Scope and Context
Overview of the Parent Market
Analyst View
Market Size and Growth
North America
Latin America
Western and Eastern Europe
Asia-Pacific
Rest of World
Segmentation
By Products
By Demography
Market Dynamics
Supply & Demand Risk
Competitive Landscape
Porter’s Five Force Model
Geographical Economic Activity
Copyright © Research Nester Pvt. Ltd. www.researchnester.com
Key Players (respective SWOT Analysis) and their
Strategies and Product Portfolio
Recent Trends and Developments
Industry Growth Drivers and Challenges
Key Information for Players to establish themselves in
current dynamic environment
To know more about this research, visit:
http://www.researchnester.com/reports/global-hepatitis-
b-therapeutic-drug-market-analysis-opportunity-outlook-
2021/57
Copyright © Research Nester Pvt. Ltd. www.researchnester.com
For More Info/Enquiry, Please Visit us at:
Research Nester Pvt. Ltd. 1820 Avenue M,
Suite #1113 Brooklyn, New York 11230
U.S. (T) +1 646 586 9123
Canada (T) +1 437 889 3230 U.K. (T) +44 203 608 5919
www.researchnester.com, [email protected]